To assess effects of CCL27 on glioma cells, we stimulated U87 and LN229 cells with recombinant human chemokine CCL27 under serum deprivation conditions and examed cell proliferation by cell count and MTT assay. This evidence concerns the gene CCL27 and central nervous system cancer.